Home Top Movers Companies Concepts

Market

Top Movers
Companies
Concepts

SEC Filings

AI Filing Analysis
Financial Reports
Current Reports
IPO Filings

Ownership

Institutional Holdings
Insider Trading

About

Data updates every 5 min
SEC EDGAR Source

© 2025–2026 StockGist|Information only, not investment advice

SCHEDULE 13G/A - Zentalis Pharmaceuticals, Inc. | StockGist | StockGist

Companies
ZNTL
SCHEDULE 13G/A

Home Top Movers Companies Concepts

Home Filings ZNTLSCHEDULE 13G/A

SCHEDULE 13G/A

Beneficial Ownership

Amendment

Zentalis Pharmaceuticals, Inc.

Filed Dec 6, 2024

Accepted Dec 5, 2024, 7:00 PM ET

CIK 0001725160

View on SEC.gov Company Profile

Beneficial Ownership Report

Passive Investment

% of Class

49.00%

Shares Owned

315,066

Reporting Person

Zentalis Pharmaceuticals, Inc.

Person Type

HC

CUSIP: 98943L107

Amendment History

3 filings

SCHEDULE 13G
Original
Dec 30, 20250001873515-25-000004
SCHEDULE 13G/A
Amendment 1
Viewing
Dec 6, 20240000315066-24-002990
SCHEDULE 13G/A
Amendment 2
Latest
Jan 5, 20260001213900-26-001456

Key Facts

% of Class

49.00%

Shares Owned

315,066

Recent Filings

Zentalis Pharmaceuticals, Inc.1 weeks ago

Zentalis Pharmaceuticals, Inc.2 months ago

Zentalis Pharmaceuticals, Inc.2 months ago

Zentalis Pharmaceuticals, Inc.3 months ago

Zentalis Pharmaceuticals, Inc.3 months ago

Data Sources

Original SEC Filing SEC EDGAR Company Page

Market

Top Movers
Companies
Concepts

SEC Filings

AI Filing Analysis
Financial Reports
Current Reports
IPO Filings

Ownership

Institutional Holdings
Insider Trading

About

Data updates every 5 min
SEC EDGAR Source

© 2025–2026 StockGist|Information only, not investment advice